Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$16.10 - $29.55
Next Earnings Date
May 08 2025
Next Earnings Date
May 08 2025
Latest price
Market Cap | $1.14B |
EV | $1.06B |
Shares Outstanding | 47.02M |
Beta | 1.93 |
Analyst Rating | BUY |
Analyst Target Price | $31.33 |
P/E 2025E | - |
P/Revenue 2025E | 11.77x |
Revenue | -11.60% |
EPS | -26.00% |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | 21.60% |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | 74.30% |
Gross Margin 2025E | 63.83% |
Net Profit Margin 2025E | -6.63% |
ROE 2025E | -1.10% |
ROCE 2024 | -3.32% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
BioLife Solutions, Inc.
BLFS
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
de Greef, Roderick
Employees
159
Website
www.biolifesolutions.comIPO Date
1989-11-22
Headquarters
3303 Monte Villa Parkway, Suite 310, Bothell, Washington, 98021, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved